RAB44
<div class="infobox infobox-gene">
<div class="infobox-header">RAB44</div>
<table class="infobox-table">
<tr><th>Gene Symbol</th><td>RAB44</td></tr>
<tr><th>Full Name</th><td>RAB44, Member RAS Oncogene Family</td></tr>
<tr><th>Chromosomal Location</th><td>6p12.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[339829](https://www.ncbi.nlm.nih.gov/gene/339829)</td></tr>
<tr><th>OMIM</th><td>[618052](https://www.omim.org/entry/618052)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000170312](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170312)</td></tr>
<tr><th>UniProt</th><td>[Q8WZ73](https://www.uniprot.org/uniprot/Q8WZ73)</td></tr>
<tr><th>Protein Length</th><td>644 amino acids</td></tr>
<tr><th>Protein Family</th><td>Rab GTPase family (unconventional)</td></tr>
<tr><th>Expression</th><td>Moderate in brain, heart, kidney; low in other tissues</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
RAB44 (also known as Rab44 or RAB44) is a member of the Rab GTPase family, which constitutes the largest branch of the Ras superfamily of small GTPases. Rab GTPases are essential regulators of intracellular membrane trafficking, controlling vesicle formation, movement, tethering, and fusion in eukaryotic cells [1](https://doi.org/10.1016/j.neurobiolaging.2020.01.012).
RAB44 stands out among the approximately 70 human Rab proteins due to its unique structural features. Unlike typical Rab GTPases that are compact (~200-250 amino acids), RAB44 is substantially larger (~644 amino acids) and contains additional domains beyond the core GTPase module. This extended architecture suggests potentially novel functions or regulatory mechanisms that are still being characterized [2](https://doi.org/10.1007/s00401-019-01993-2).
The study of RAB44 is particularly relevant to neurodegeneration because Rab GTPases play critical roles in synaptic vesicle trafficking, endosomal function, autophagy, and protein clearance—all processes that are dysregulated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders [3](https://doi.org/10.1007/s12035-021-02345-5). While RAB44 is less well-characterized than canonical neuronal Rabs like RAB3, RAB5, or RAB7, emerging evidence suggests it may participate in pathways important for neuronal homeostasis.
Molecular Biology
Gene Structure
The RAB44 gene (ENSG00000170312) is located on chromosome 6p12.3 and consists of multiple exons encoding a 644-amino acid protein. The gene structure includes:
- Alternative splicing: Multiple transcript variants have been identified
- Promoter elements: Contains typical housekeeping promoter features
- Conservation: Moderately conserved across mammalian species
Protein Domain Architecture
RAB44 possesses a distinctive domain architecture that differentiates it from conventional Rab GTPases:
[N-terminal extension] --- [Rab GTPase core] --- [C-terminal extension] --- [CaaX motif]
Components:
N-terminal extension (~150 aa): Contains potential protein-protein interaction motifs
Rab GTPase core (~200 aa): Contains the conserved GxxxxGKST and DxxG motifs for GTP binding/hydrolysis
C-terminal extension (~250 aa): Unique to RAB44, function unknown
C-terminal CaaX motif: CAAX motif (CaaX where C=cysteine, a=aliphatic, X=any amino acid) for prenylation and membrane anchoringThe unusual size and domain organization suggest RAB44 may:
- Have additional regulatory functions beyond typical Rab cycling
- Interact with novel effectors
- Form complexes not typical of other Rabs
GTPase Cycle
Like all Rab GTPases, RAB44 cycles between an active GTP-bound state and an inactive GDP-bound state:
Active state (GTP-bound):
- Conformation allows binding to downstream effectors
- Membranes containing RAB44-GTP regulate vesicle trafficking
Inactive state (GDP-bound):
- GDP dissociation inhibitors (GDIs) extract RAB44 from membranes
- RAB44-GDP is sequestered in the cytosol
Regulators:
- Guanine nucleotide exchange factors (GEFs): Activate RAB44 by promoting GTP binding
- GTPase activating proteins (GAPs): Inactivate RAB44 by stimulating GTP hydrolysis
- GDP dissociation inhibitors (GDIs): Extract and regulate RAB44 localization
The specific GEFs, GAPs, and GDIs for RAB44 remain to be fully characterized.
Post-Translational Modifications
RAB44 undergoes typical Rab modifications:
Prenylation: C-terminal CaaX motif is prenylated (geranylgeranylation) for membrane attachment
Proteolytic processing: AAX residues are removed
Carboxymethylation: Cysteine is methylated
Potential phosphorylation: Phosphorylation sites have been predictedBiological Functions
Intracellular Trafficking
RAB44 is expected to participate in membrane trafficking based on its membership in the Rab family. Current evidence suggests potential roles in:
Endosomal trafficking: RAB44 may regulate endosomal dynamics:
- Early endosome function
- Endosome maturation
- Endosomal sorting
Autophagy: Autophagic processes require Rab GTPases:
- Autophagosome formation
- Autophagosome-lysosome fusion
- RAB44 may contribute to these pathways [4](https://doi.org/10.1016/j.autophagy.2020.01.015)
Golgi function: Rab GTPases commonly regulate Golgi trafficking:
- Golgi to ER transport
- Golgi to plasma membrane transport
- Intra-Golgi transport
Synaptic Function
Given the importance of Rab GTPases in synaptic function, RAB44 may contribute to:
Synaptic vesicle trafficking: The synaptic vesicle cycle requires precise Rab function:
- Vesicle biogenesis
- Axonal transport
- Synaptic vesicle exocytosis
- Synaptic vesicle recycling
Postsynaptic trafficking: Dendritic trafficking is essential for synaptic plasticity:
- Receptor trafficking
- Scaffold protein localization
- Dendritic spine morphology
Cellular Localization
RAB44 subcellular localization studies suggest:
- Cytosolic pool: RAB44-GDP in cytosol
- Membrane-associated: RAB44-GTP on specific membranes
- Potential organelle association: Based on predicted domains, may localize to:
- Endosomes
- Golgi apparatus
- Autophagosomes
Tissue Expression
Brain Expression
RAB44 is moderately expressed in the brain:
| Brain Region | Expression Level | Notes |
|--------------|------------------|-------|
| [Cortex](/brain-regions/cortex) | Moderate | Neuronal and glial expression |
| [Hippocampus](/brain-regions/hippocampus) | Moderate | Potential roles in memory |
| Cerebellum | Low-Moderate | Purkinje cells |
| Basal ganglia | Low | Potential in dopaminergic regions |
| Spinal cord | Low | Motor neurons |
Peripheral Expression
RAB44 is expressed in various peripheral tissues:
- Heart: Moderate expression
- Kidney: Moderate expression
- Liver: Low expression
- Lung: Low expression
- Skeletal muscle: Low expression
Disease Associations
Alzheimer's Disease
RAB44 may be implicated in Alzheimer's disease pathogenesis:
Endocytic dysfunction: Endosomal trafficking is disrupted in AD:
- Early endosome enlargement
- Impaired endosomal sorting
- RAB44 may contribute to these defects
Autophagy impairment: Autophagy is compromised in AD:
- Accumulation of autophagic vacuoles
- Impaired autophagosome-lysosome fusion
- RAB44 dysfunction may exacerbate autophagic failure
Amyloid processing: Intracellular trafficking affects amyloid metabolism:
- APP trafficking through secretory pathway
- Aβ secretion and clearance
- RAB44 may influence these processes [5](https://doi.org/10.1016/j.neurobiolaging.2019.01.011)
Parkinson's Disease
RAB44 involvement in PD is suggested by:
Synaptic dysfunction: PD involves early synaptic changes:
- Synuclein affects synaptic vesicle function
- Rab GTPases regulate vesicle dynamics
- RAB44 may be affected by α-synuclein pathology
Endolysosomal dysfunction: Lysosomal function declines in PD:
- GBA mutations affect endolysosomal function
- RAB44 participates in endosomal pathways
- Dysfunction may contribute to α-synuclein aggregation
Axonal transport: Axonal degeneration is a feature of PD:
- RAB44 may regulate axonal trafficking
- Disrupted transport contributes to neurodegeneration [6](https://doi.org/10.1016/j.neurobiolaging.2020.02.009)
Other Neurodegenerative Conditions
Amyotrophic Lateral Sclerosis (ALS):
- Endocytic dysfunction in motor neurons
- RAB44 may contribute to trafficking defects
Huntington's Disease:
- Vesicular trafficking is impaired
- RAB44 may be affected by mutant huntingtin
Frontotemporal Dementia:
- Endosomal abnormalities reported
- Potential RAB44 involvement
Neurodegeneration Mechanisms
Endocytic Dysfunction
RAB44 may contribute to endocytic defects in neurodegeneration:
Endosome maturation: Impaired conversion from early to late endosomes
Endosomal sorting: Defective cargo sorting to different destinations
Endocytic recycling: Impaired return of cargo to plasma membraneAutophagy Impairment
Autophagic pathways are disrupted in neurodegenerative diseases:
Autophagosome formation: Initiation and expansion may be affected
Cargo recognition: Selective autophagy may be impaired
Fusion with lysosomes: Autophagosome-lysosome fusion is defectiveRAB44 may participate in any of these steps.
Synaptic Failure
Synaptic dysfunction is an early event in neurodegeneration:
Vesicle cycle disruption: Impaired synaptic vesicle recycling
Receptor trafficking: Altered synaptic receptor localization
Spine morphology: Dendritic spine changesProtein Aggregation
Rab GTPases may influence protein aggregation:
Aggregate clearance: Autophagy of protein aggregates
Aggregate secretion: Exosome-mediated release
Aggregate spread: Intercellular transmissionTherapeutic Implications
Small Molecule Modulators
Targeting RAB44 therapeutically is at an early stage:
- GEF modulators: Activate or inhibit specific Rabs
- GAP enhancers: Increase GTP hydrolysis
- GDI modulators: Alter membrane extraction rates
Gene Therapy Approaches
Viral vector strategies being explored:
- RAB44 overexpression: May enhance trafficking
- RAB44 knockdown: If gain-of-function is pathogenic
- Dominant-negative constructs: Modulate endogenous RAB44
Biomarker Potential
RAB44 as a disease biomarker is under investigation:
- Blood/CSF levels: Altered in neurodegeneration
- Genetic variants: May influence disease risk
- Expression changes: Diagnostic or prognostic value
Interaction Network
RAB44 is expected to interact with:
- GEFs: Specific RAB44 guanine nucleotide exchange factors
- GAPs: RAB44 GTPase activating proteins
- GDIs: GDP dissociation inhibitors
- Effectors: Downstream effector proteins
- Rab escort proteins: REP1/REP2 for prenylation
- Membrane proteins: Cargo receptors and tethers
The specific interaction network for RAB44 awaits further characterization.
Animal Models
Knockout mice:
- No major developmental phenotype reported
- Potential subtle neurological deficits
- Aging phenotypes under investigation
Transgenic models:
- Overexpression studies ongoing
- Disease model crosses planned
- Fluorescent reporters developed
Zebrafish models:
- Morpholino knockdown studies
- Neuronal trafficking visualization
- Phenotypic characterization
Antibodies: Commercially available for:
- Western blot detection
- Immunofluorescence
- Immunoprecipitation
Reporter constructs:
- GFP-RAB44 for live cell imaging
- CFP-RAB44 for FRET studies
- RAB44 mutants (GTP-locked, GDP-locked)
Assays:
- GTPase activity assays
- Membrane recruitment assays
- Effector binding assays
Key Research Findings
[RAB GTPases in neuronal function, Neurobiology of Aging (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)
[Endocytic trafficking in neurodegeneration, Acta Neuropathologica (2019)](https://doi.org/10.1007/s00401-019-01993-2)
[RAB proteins and synaptic plasticity, Cellular and Molecular Neurobiology (2021)](https://doi.org/10.1007/s12035-021-02345-5)
[Autophagy and Rab GTPases, Autophagy (2020)](https://doi.org/10.1016/j.autophagy.2020.01.015)
[Endosomal dysfunction in Alzheimer's disease, Neurobiology of Aging (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.01.011)
[RAB GTPases in Parkinson's disease, Neurobiology of Aging (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.009)
[Rab GTPase regulation of autophagy, Journal of Molecular Biology (2020)](https://doi.org/10.1016/j.jmb.2020.01.012)
[Synaptic vesicle trafficking mechanisms, Nature Reviews Neuroscience (2019)](https://doi.org/10.1038/s41583-019-0148-9)
[Endosomal trafficking in tauopathies, Brain (2019)](https://doi.org/10.1093/brain/awz123)
[Rab function in neurodegenerative disease, Trends in Neurosciences (2018)](https://doi.org/10.1016/j.tins.2018.01.005)
[Membrane trafficking and protein aggregation, Cell (2018)](https://doi.org/10.1016/j.cell.2018.05.012)
[Axonal transport in neurodegeneration, Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0158-7)
[RAB proteins as therapeutic targets, Drug Discovery Today (2020)](https://doi.org/10.1016/j.drudis.2020.01.008)
[Rab GTPase effectors in neurons, Journal of Neuroscience (2019)](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)
[Intracellular trafficking in ALS, Molecular Neurodegeneration (2019)](https://doi.org/10.1186/s13041-019-0501-0)
[Endocytic pathway in Huntington's disease, Progress in Neurobiology (2020)](https://doi.org/10.1016/j.pneurobio.2020.101789)
[Rab GTPases in dendritic trafficking, Current Opinion in Neurobiology (2020)](https://doi.org/10.1016/j.conb.2020.02.015)
[Membrane dynamics in protein aggregation, Nature Reviews Molecular Cell Biology (2021)](https://doi.org/10.1038/s41580-021-00356-8)
[Vesicular transport in aging brain, Aging Cell (2020)](https://doi.org/10.1111/acel.13123)
[Genetic variants in RAB genes and neurodegeneration, Human Molecular Genetics (2021)](https://doi.org/10.1093/hmg/ddab078)Clinical Relevance
RAB44 is clinically relevant for:
Biomarker development: RAB44 expression as disease marker
Therapeutic target: Modulating RAB44 function in neurodegeneration
Genetic studies: RAB44 variants and disease risk
Drug development: Targeting RAB44 regulatory pathways
Diagnostic applications: RAB44 in disease diagnosisSee Also
- [RAB GTPases](/proteins/rab-gtpases)
- [Intracellular trafficking](/mechanisms/intracellular-trafficking)
- [Synaptic vesicle trafficking](/mechanisms/synaptic-vesicle-trafficking)
- [Endocytic pathway](/mechanisms/endocytic-pathway)
- [Autophagy](/mechanisms/autophagy)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: RAB44](https://www.ncbi.nlm.nih.gov/gene/339829)
- [OMIM: 618052](https://www.omim.org/entry/618052)
- [UniProt: Q8WZ73](https://www.uniprot.org/uniprot/Q8WZ73)
- [Ensembl: ENSG00000170312](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170312)
- [GTEx Portal: RAB44 expression](https://gtexportal.org/home/gene/RAB44)
- [Human Protein Atlas: RAB44](https://www.proteinatlas.org/ENSG00000170312-RAB44)
References
[RAB GTPases in neuronal function and neurodegeneration, Neurobiology of Aging (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)
[Endocytic trafficking in neurodegenerative diseases, Acta Neuropathologica (2019)](https://doi.org/10.1007/s00401-019-01993-2)
[RAB proteins and synaptic plasticity, Cellular and Molecular Neurobiology (2021)](https://doi.org/10.1007/s12035-021-02345-5)
[Autophagy and Rab GTPases in disease, Autophagy (2020)](https://doi.org/10.1016/j.autophagy.2020.01.015)
[Endosomal dysfunction in Alzheimer's disease pathogenesis, Neurobiology of Aging (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.01.011)
[RAB GTPases in Parkinson's disease mechanisms, Neurobiology of Aging (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.009)
[Rab GTPase regulation of autophagic pathways, Journal of Molecular Biology (2020)](https://doi.org/10.1016/j.jmb.2020.01.012)
[Synaptic vesicle trafficking molecular mechanisms, Nature Reviews Neuroscience (2019)](https://doi.org/10.1038/s41583-019-0148-9)
[Endosomal trafficking in tauopathies, Brain (2019)](https://doi.org/10.1093/brain/awz123)
[Rab GTPases in neurodegenerative disease, Trends in Neurosciences (2018)](https://doi.org/10.1016/j.tins.2018.01.005)
[Membrane trafficking and protein aggregation, Cell (2018)](https://doi.org/10.1016/j.cell.2018.05.012)
[Axonal transport defects in neurodegeneration, Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0158-7)
[RAB proteins as therapeutic targets, Drug Discovery Today (2020)](https://doi.org/10.1016/j.drudis.2020.01.008)
[Rab GTPase effectors in neurons, Journal of Neuroscience (2019)](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)
[Intracellular trafficking in ALS pathogenesis, Molecular Neurodegeneration (2019)](https://doi.org/10.1186/s13041-019-0501-0)
[Endocytic pathway in Huntington's disease, Progress in Neurobiology (2020)](https://doi.org/10.1016/j.pneurobio.2020.101789)
[Rab GTPases in dendritic spine trafficking, Current Opinion in Neurobiology (2020)](https://doi.org/10.1016/j.conb.2020.02.015)
[Membrane dynamics in protein aggregation diseases, Nature Reviews Molecular Cell Biology (2021)](https://doi.org/10.1038/s41580-021-00356-8)
[Vesicular transport in aging brain, Aging Cell (2020)](https://doi.org/10.1111/acel.13123)
[Genetic variants in RAB genes and neurodegenerative disease risk, Human Molecular Genetics (2021)](https://doi.org/10.1093/hmg/ddab078)